I've been using pathway analysis methods like GSEA and GSVA, which evaluate pathway activity based on gene expression levels. However, these methods seem to assume that the more highly expressed a gene is, the more it contributes to pathway activation. This seems to oversimplify how many biological pathways work, where genes within the same pathway can have different activation requirements:
- Some genes (e.g., activators) need to be upregulated for a pathway to be active.
- Others (e.g., inhibitors or regulatory genes) need to be downregulated or remain at baseline levels for proper activation.
Given this, I’m wondering:
- Are there any methods or modifications to GSEA or GSVA that account for the fact that some genes in a pathway may need to be downregulated or have specific expected activation levels for the pathway to function properly?
- Alternatively, are there tools that incorporate the biological roles of genes (activators vs. inhibitors) into pathway analysis, rather than just relying on overall expression levels?
Also:
- Do public databases like KEGG contain information on the gene role within a pathway? For example, this gene should be highly expressed, or lowly expressed?
I’m curious how others approach this issue and whether there are tools or methods that explicitly address it. Any insights or suggestions would be greatly appreciated!